Who We Are

Executive Advisory Board:

Scientific Advisory Board:

Charles Cotropia, CEO, Juris Doctorate Degree Cornell Univ.,           B.S. Aerospace Engineering Univ. of Texas

Joseph Cotropia, CSO, Doctor of Medicine Degree Univ. of Texas Southwestern Medical School, M.S. Physiological Chemistry

Gaurav Chandra, COO, Doctor of Medicine Degree Kasturba Medical School Manipal, FAGE, MBA, Head of Research and Development

Paul D. Fellegy
CFO

Tomasz Zastawny, Chief Clinical Operations Officer, DSc, Ph.D.

Ellen S. Vitetta, Ph.D.
Professor at the University of Texas Southwestern Medical Center at Dallas, The Scheryle Simmons Patigian Distinguished Chair in Cancer Immunobiology at the  Cancer Immunobiology Center, Director Graduate School of Biomedical Sciences Center for Immunology
Dallas, Texas
 
Yvonne J. Bryson, M.D.
Professor of Pediatrics and Chief, Division of Pediatric Infectious Diseases, David Geffen School of Medicine, Mattel Children's Hospital at UCLA, Marian Davies Children Center
Los Angeles, California
 
Dalila B. Corry, M.D.
Professor of Clinical Medicine, Chief, Division of Nephrology, David Geffen School of Medicine at UCLA
Los Angeles, California

INVEST NOW

     As we prepare to take our technology to the next level, we are raising funds from accredited investors.  Contact us at csc@bioclonetics.com for more information.  In this fund raise, we are seeking a raise from $200,000 to $1,000,000 with investments taken and secured by a SAFE (Simple Agreement for Future Equity) with a $15 Million cap on our company valuation and a 30% premium provided to investors during this round. The terms of our raise are provided in the SAFE (Simple Agreement for Future Equity) Agreement provided to prospective accredited investors.

CONSIDER INVESTING NOW

            If you would like to help us reach our goal of a therapeutic cure for HIV, there are a couple of ways you can support our success and growth:

1.     if you are an accredited investor,

      - Consider investing in this financing round.  Contact us at csc@bioclonetics.com.

2.     If you are not in a position to invest now, but still want to help, then:

     - Share this information with friends who might be interested in this type of investment.

     - Share our profile through your social media networks.

OUR FUTURE PLANS

     We are currently in discussions with Serum Institute of India (www.seruminstitute.com) to partner in advancing our technology through clinical trials.  Serum Institute is the largest producer of vaccines in the world and a producer of several monoclonal antibodies against other infectuous diseases.  Join us in this journey to cure HIV using monoclonal antibodies.